[Role of the new beta lactams in severe infections. Imipenem and aztreonam: indications and limitations].
Sánchez
C
C
Garau
J
J
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001398:Aztreonam / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D006801:Humans; D015378:Imipenem / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D015378:Imipenem; D001398:Aztreonam
Papel de los nuevos betalactámicos en las infecciones graves. Imipenem y aztreonam: indicaciones y limitaciones.